Company intelligence / Profile preview

Evofem Biosciences, Inc.

San Diego, California, United Statesevofem.com ↗
Ownership
Public · EVFM
Employees
~75
Development stage
Commercial
01

Overview

Evofem Biosciences has commercialized Phexxi®, an FDA-approved hormone-free contraceptive vaginal gel. The company also markets SOLOSEC®, an FDA-approved single-dose oral antibiotic for the treatment of bacterial vaginosis and trichomoniasis. Pipeline programs include EVO100 for STI prevention in Phase 3 trials and EVO200 for recurrent BV in early clinical stages. A multipurpose product candidate targeting HIV prevention via a partnership with Orion Biotechnology remains preclinical[5][6][7][9].

Therapeutic areas
Infectious DiseasesWomen's Health
Modalities
vaginal pH modulators (non-hormonal)oral antibiotics
Industry
Biotech
02

Drug pipeline

5 assets

potassium bitartrate

Approved

4 more assets in the full pipeline.

03

Partnerships

Windtree Therapeutics (manufacturing/supply agreement for Phexxi)[7]Orion Biotechnology Canada Ltd. (collaboration on MPT/HIV product)[9]Pharma1 Drug Store UAE (international licensing/distribution)[7]
04

Financials

Market cap
$795.2K
Total revenue
$20.2M
Enterprise value
$69M

Beyond the preview

Go deeper on Evofem Biosciences, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evofem Biosciences, Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call